257.12MMarket Cap
LossP/E TTM
Key Figures
18.330Open
19.290High
170.49KVolume
LossP/E TTM
179.18P/E Dynamic
--Dividend TTM
1.28%Turnover Ratio
18.070Prev. Close
17.870Low
2.61MTurnover
LossP/E Static
1.92P/B
0.00%Div Yield TTM
-5.99%ROA
16.24052wk High
2.20Volume Ratio
-56.38MNet Profit
13.36MShares
-0.7916EPS TTM
0.22Beta
-7.85%ROE
7.87052wk Low
7.86%Amplitude
65.15%Gross Margin
257.12MMarket Cap
6.17Reward/Risk
2.86%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Anika Therapeutics Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 6 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 19.00.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Anika Therapeutics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Anika Therapeutics Inc Highlights
StrengthsRisks
Anika Therapeutics Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Anika Therapeutics Inc
ANIK
2
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Anika Therapeutics Inc Info
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
Ticker SymbolANIK
CompanyAnika Therapeutics Inc
CEOBlanchard (Cheryl Renee)
Websitehttps://anika.com/
Shareholders
FAQs
What is the current price of Anika Therapeutics Inc (ANIK)?
The current price of Anika Therapeutics Inc (ANIK) is 19.25.
What is the symbol of Anika Therapeutics Inc?
The ticker symbol of Anika Therapeutics Inc is ANIK.
What is the 52-week high of Anika Therapeutics Inc?
The 52-week high of Anika Therapeutics Inc is 16.24.
What is the 52-week low of Anika Therapeutics Inc?
The 52-week low of Anika Therapeutics Inc is 7.87.
What is the market capitalization of Anika Therapeutics Inc?
The market capitalization of Anika Therapeutics Inc is 257.12M.
Is Anika Therapeutics Inc (ANIK) currently rated as Buy, Hold, or Sell?
According to analysts, Anika Therapeutics Inc (ANIK) has an overall rating of STRONG BUY, with a price target of 19.00.
What is the Earnings Per Share (EPS TTM) of Anika Therapeutics Inc (ANIK)?
The Earnings Per Share (EPS TTM) of Anika Therapeutics Inc (ANIK) is -0.76.
